Edwards Lifesciences Corp (EW)vsENvue Medical Inc. (FEED)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
FEED
ENvue Medical Inc.
$2.26
+58.04%
HEALTHCARE · Cap: $1.31M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 225881% more annual revenue ($6.07B vs $2.69M). EW leads profitability with a 17.7% profit margin vs -2.5%. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
FEED
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Intrinsic value data unavailable for FEED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
Revenue surging 92.0% year-over-year
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -30.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : FEED
The strongest argument for FEED centers on Price/Book, Revenue Growth. Revenue growth of 92.0% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : FEED
The primary concerns for FEED are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a mature stock while FEED is a hypergrowth play — different risk/reward profiles.
FEED carries more volatility with a beta of 2.28 — expect wider price swings.
FEED is growing revenue faster at 92.0% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 41/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →ENvue Medical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
ENvue Medical Inc. (FEED) is a forward-thinking healthcare technology firm committed to revolutionizing patient care management through advanced medical devices and software solutions. By harnessing innovative technology, ENvue Medical focuses on optimizing recovery processes and improving health outcomes across various clinical settings. The company's robust product pipeline, coupled with strategic collaborations, positions it well to capitalize on the growth of the healthcare industry, presenting a compelling investment opportunity for institutional investors seeking exposure to the dynamic fields of medical device innovation and digital health advancements.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?